(NYSE: CRM), the world’s #1 AI CRM, today announced it has completed its acquisition of Informatica, a leader in enterprise AI-powered cloud data management. The close of the acquisition brings ...

LOS ANGELES, Nov. 12, 2025 /PRNewswire/ -- Diversis Capital, a leading lower middle market technology investment firm with $3 billion in assets under management, today announced it has completed the ...

CT Mirror’s independent, nonprofit journalism depends on reader support. Connecticut families receiving at least $25 in SNAP benefits will lose nearly $200 monthly on average if cuts take effect in ...

Power Integrations outlined the benefits of its PowiGaN gallium-nitride technology for next-generation AI data centres. The capabilities of 1250V and 1700V PowiGaN technology for 800VDC power ...

The MarketWatch News Department was not involved in the creation of this content. Snowflake, Baptist Health, and Verato power AI-ready digital transformation with identity intelligence ORLANDO, Fla., ...

ORLANDO, Fla., Oct. 14, 2025 /PRNewswire/ -- Gartner IT Symposium/Xpo -- Verato®, the identity intelligence experts, today announced a panel discussion, "Unlock AI-Ready Digital Transformation with ...

As Giant Eagle expands its pharmacy business by absorbing customers from the failed Rite-Aid chain, it quietly has been making a bigger push into a more obscure sector of the industry: pharmacy ...

Icotrokinra met the primary endpoint of clinical response at all three doses, with 36.5% of patients treated achieving endoscopic improvement and 30.2% achieving clinical remission at the highest dose ...

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) ranks among the best biotech stocks to buy. On September 17, Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) revealed the findings of its Phase 2 COURAGE ...

The growing multi-chronic epidemic and its impact on health care costs is driving the need for more effective cost-containment strategies. Vendors providing condition management solutions offer ...

ARTIOS Phase IIIb, open-label, single-arm, prospective study showed a substantial reduction in disease activity in people with relapsing multiple sclerosis (RMS) following switch to Kesimpta after ...

In 2012, shortly after working for a chain pharmacy, I opened DePietro’s Pharmacy. I quickly realized patients deserved more personal attention than what was offered at a chain pharmacy. Since opening ...